Radiation and Your Patient

Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer

Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer

Hypofractionated regimen of precision radiotherapy was not inferior to conventional RT in patients with intermediate-risk prostate cancer.

Temozolomide With Radiotherapy for Glioblastoma Provides Some Survival Benefit in Elderly

Temozolomide With Radiotherapy for Glioblastoma Provides Some Survival Benefit in Elderly

The addition of temozolomide to short-course radiotherapy in elderly patients with glioblastoma was associated with some survival benefit compared with radiotherapy alone.

Evidenced-Based Radiation Treatment Tied to Cost Savings in Early Stage Breast Cancer

Evidenced-Based Radiation Treatment Tied to Cost Savings in Early Stage Breast Cancer

Health care costs lower for early-stage breast cancer when adjuvant radiation therapy follows evidence-based guidelines.

Chemotherapy or VBT Improve Survival in Uterine Papillary Serous Carcinoma

Chemotherapy or VBT Improve Survival in Uterine Papillary Serous Carcinoma

Use of chemotherapy or vaginal brachytherapy (VBT) may improve survival among patients with early-stage uterine papillary serous carcinoma.

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

Shorter course of higher dose radiation therapy provide effective treatment, costs less, and is easier on patients than current standard radiation therapy course.

Risk of Lung Cancer Increases After Radiation for Breast Cancer

Risk of Lung Cancer Increases After Radiation for Breast Cancer

Treatment with radiation therapy for invasive breast cancer may place East Asian women at a greater risk of developing second primary lung cancer (SPLC).

Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments

Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments

Elderly with NSCLC have lower incidence of esophagitis, can tolerate aggressive radiation therapy.

GARD: A Move Toward Precision Radiation Therapy

GARD: A Move Toward Precision Radiation Therapy

A new tool may enable oncologists to deliver radiation therapy targeted to a tumor's biology and radiosensitivity, similar to how anticancer agents target specific tumor mutation-affected gene pathways.

Shared Decision Making Will Require New Tools, Paradigms in Radiation Oncology

Shared Decision Making Will Require New Tools, Paradigms in Radiation Oncology

A recent paper on the future of radiation oncology reports on the trend toward a greater role for shared decision making and patient-reported outcomes, such as the interrelated benchmarks of patient satisfaction, engagement, and treatment-plan adherence.

Gero-Oncology: Preparing for the Coming Wave of Elderly Cancer Patients

Gero-Oncology: Preparing for the Coming Wave of Elderly Cancer Patients

A growing proportion of cancer patients are elderly—creating a demographic shift with important implications for cancer care, including radiotherapy. Integrating geriatric care into oncology nursing has never been more important.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs